Position in TMO
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,386,761
+$23,257 QoQ
Shares Held
2,766
-0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#1,305
of 2,606 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 29%
Shared 0%
None 71%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Family Legacy, Inc. holds $2,537,260 across 2 Diagnostics & Research names. TMO ranks #1 (54.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
2,766 | $1,386,761 | |
| 2 | DHR |
Danaher Corp /De/
|
6,040 | $1,150,499 |
All Filings in TMO
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,386,761 | 2,766 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,363,504 | 2,774 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,591,749 | 2,747 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,324,589 | 2,731 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,105,689 | 2,727 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $1,338,544 | 2,690 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,385,892 | 2,664 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,556,940 | 2,517 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,332,730 | 2,410 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $1,376,305 | 2,368 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $1,221,347 | 2,301 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $1,111,043 | 2,195 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $1,110,284 | 2,128 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $1,211,529 | 2,102 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,063,933 | 1,932 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||